Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics.

  PMID 41813823 · PMC12996285 · NPJ precision oncology · 2026 · 8 claims · 8 setups

  Full-text index only

  A progenitor-like CD38+CD45RA+ leukemic cell population is associated with midostaurin resistance

  bm-mncs flt3mut drug ms-based rna-sequencing

• Out-of-frame CBX3::ALK fusion drives ALK activation and therapy response.

  PMID 41887222 · PMC13130619 · Cell reports. Medicine · 2026 · 8 claims · 8 setups

  Full-text index only

  A CBX3::ALK out-of-frame fusion was identified in a patient with metastatic melanoma

  metastatic cutaneous tumor hek293t targeted immunohistochemistry fluorescence

• CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia.

  PMID 41844049 · PMC13010944 · Neoplasia (New York, N.Y.) · 2026 · 8 claims · 8 setups

  Full-text index only

  CEBPD is identified as a novel tumor suppressor gene in AML

  paired aml tcga oci-aml5 bulk bart kaplan-meier